Last data update: May 26, 2022. (Total: 3849 publications since 2011)
|Query Trace: all>>Patricia J Campbell[CDC Author]|
| Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
Patricia J Campbell, Glenn P Morlock, R David Sikes, Tracy L Dalton, Beverly Metchock, Angela M Starks, Delaina P Hooks, Lauren S Cowan, Bonnie B Plikaytis, and James E Posey
Antimicrobial agents and chemotherapy 2011 May 55(5) 2032-41
Similar articles in PubMed DOI:10.1128/AAC.01550-10
| Disparities in capreomycin resistance levels associated with the rrs A1401G mutation in clinical isolates of Mycobacterium tuberculosis.
Analise Z Reeves, Patricia J Campbell, Melisa J Willby, and James E Posey
Antimicrob. Agents Chemother. 2015 Jan 59(1) 444-9
Similar articles in PubMed DOI:10.1128/AAC.04438-14